FDA: Two More Eye Drop Brands Recalled Due to Risks

WASHINGTON (AP) – U.S. health officials are warning consumers about two more recalls of eye drops due to contamination risks that could cause vision problems and serious injuries.

The announcements follow a recall last month of eye drops made in India linked to an outbreak of drug-resistant infections. One person died and at least five others suffered permanent vision loss.

There is no indication that the latest recalls are related to these products.

The Food and Drug Administration issued separate recall notices for certain eye drops distributed by Pharmedica and Apotex after the companies said they are voluntarily withdrawing several batches of their products.

Pharmedica said Friday it is recalling two quantities of Pure Sedative 1[ads1]5% MSM drops due to problems “that could lead to blindness.” The over-the-counter drops are designed to treat eye irritation. The Phoenix-based company said consumers should immediately stop using the drops and return them to the place of purchase.

The recall affects nearly 2,900 bottles, according to the company. The drops were produced in Arizona.

Last week, the FDA issued a separate recall notice from Apotex recalling six many prescription eye drops used to treat a form of glaucoma. The company said it initiated the recall after finding cracks in some bottle caps.

The drops are distributed as brimonidine tartrate ophthalmic solution. 0.15% and was sold from April to February.

Both companies said the recalls were done in consultation with the FDA.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. AP is solely responsible for all content.